Taher Valika
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Taher Valika has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Sarah E. Maurrasse
Department of Surgery, Division of Otolaryngology Yale University New Haven Connecticut USA
7 shared publications Jennifer M. Lavin
6 shared publicationsRashmi Kabre
6 shared publicationsAnna S Kenny
5 shared publicationsAnthony C Chin
5 shared publicationsDana M Thompson
5 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Springer Nature in Dysphagia
- p. 1-9
Intraoperative Objective Evaluation of Pediatric Cricopharyngeal Dysfunction Using Functional Luminal Imaging Probe: A Case Series
- 4 November 2026
- Published by Springer Nature in Dysphagia
- p. 1-9
Open AccessIntraoperative Objective Evaluation of Pediatric Cricopharyngeal Dysfunction Using Functional Luminal Imaging Probe: A Case Series
- 16 July 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (12) , E172-E173
In Response to Safety Profile of Nebulized Ciprofloxacin‐Dexamethasone After Pediatric Airway Surgery
- 16 July 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (12) , E172-E173
In Response to Safety Profile of Nebulized Ciprofloxacin‐Dexamethasone After Pediatric Airway Surgery
- Open Access
- 27 May 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (10) , 4514-4518
Safety Profile of Nebulized Ciprofloxacin‐Dexamethasone After Pediatric Airway Surgery
Objective: To evaluate the safety profile and patterns of use of nebulized ciprofloxacin–dexamethasone (CPD) in pediatric patients undergoing airway surgery. Methods: A retrospective chart review was performed of patients who underwent airway surgery at a tertiary pediatric center between 2019 and 2023 and received nebulized CPD 0.3%–0.1% postoperatively. Demographic, clinical, and procedural data were extracted. Exposure was defined as any postoperative nebulized administration. Adverse events were considered potentially CPD‐related if they occurred during administration or within 30 days of discontinuation without a better explanation. Outcomes included endocrine, metabolic, infectious, pulmonary, and inflammatory complications. Results: A total of 399 patients received nebulized CPD. Mean age was 46.2 months (range: newborn–20.7 years). Indications included subglottic stenosis (92.5%), post‐laryngotracheal reconstruction (5.3%), airway foreign body (2.0%), and supraglottoplasty (0.3%). Comorbidities were frequent, including neurologic conditions (47.6%), cardiac anomalies (41.6%), and bronchopulmonary dysplasia (25.1%). Most patients (93.4%) received CPD in the inpatient setting, for a mean duration of 11.7 days. No cases of adrenal suppression, glucose abnormalities, or bronchial hyperreactivity were identified. One patient had suspected airway fungal infection while receiving chemotherapy, though pathology was negative. Among the 85.7% of patients who underwent postoperative endoscopic evaluation, no significant inflammatory findings were observed. Conclusion: Nebulized CPD Was Uniformly Incorporated Into Postoperative Airway Management in This Large Pediatric Cohort and Well Tolerated, With no Significant Adverse Events Observed. These Findings Support the Safety of CPD in Medically Complex Children and Highlight the Need for Multicenter Prospective Studies to Evaluate Efficacy and Optimize Dosing Protocols. Level of Evidence: 3
- 27 May 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (10) , 4514-4518
Open AccessSafety Profile of Nebulized Ciprofloxacin‐Dexamethasone After Pediatric Airway Surgery
Objective: To evaluate the safety profile and patterns of use of nebulized ciprofloxacin–dexamethasone (CPD) in pediatric patients undergoing airway surgery. Methods: A retrospective chart review was performed of patients who underwent airway surgery at a tertiary pediatric center between 2019 and 2023 and received nebulized CPD 0.3%–0.1% postoperatively. Demographic, clinical, and procedural data were extracted. Exposure was defined as any postoperative nebulized administration. Adverse events were considered potentially CPD‐related if they occurred during administration or within 30 days of discontinuation without a better explanation. Outcomes included endocrine, metabolic, infectious, pulmonary, and inflammatory complications. Results: A total of 399 patients received nebulized CPD. Mean age was 46.2 months (range: newborn–20.7 years). Indications included subglottic stenosis (92.5%), post‐laryngotracheal reconstruction (5.3%), airway foreign body (2.0%), and supraglottoplasty (0.3%). Comorbidities were frequent, including neurologic conditions (47.6%), cardiac anomalies (41.6%), and bronchopulmonary dysplasia (25.1%). Most patients (93.4%) received CPD in the inpatient setting, for a mean duration of 11.7 days. No cases of adrenal suppression, glucose abnormalities, or bronchial hyperreactivity were identified. One patient had suspected airway fungal infection while receiving chemotherapy, though pathology was negative. Among the 85.7% of patients who underwent postoperative endoscopic evaluation, no significant inflammatory findings were observed. Conclusion: Nebulized CPD Was Uniformly Incorporated Into Postoperative Airway Management in This Large Pediatric Cohort and Well Tolerated, With no Significant Adverse Events Observed. These Findings Support the Safety of CPD in Medically Complex Children and Highlight the Need for Multicenter Prospective Studies to Evaluate Efficacy and Optimize Dosing Protocols. Level of Evidence: 3
- Open Access
- 14 November 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (6) , e70306
Infraglottic Edema and Subglottic Stenosis in Tracheostomy‐Dependent Children: A Retrospective Cohort Study
Objective: Infraglottic edema secondary to swelling of the conus elasticus is a common observation in children after tracheostomy. We sought to describe the natural course of infra‐glottic edema as seen at first direct laryngoscopy and bronchoscopy (DLB) and explore its association with developing subglottic stenosis (SGS) in tracheostomy‐dependent children. Methods: A retrospective cohort study of children who underwent tracheostomy between 2012 and 2022 in a tertiary care children's hospital. Results: A total of 255 children (mean age 3.5 ± 5.3 years) were enrolled, of whom 150 met inclusion criteria. Infraglottic edema was observed in 74 patients (49.3%) at first DLB, performed a median of 1.7 months after tracheostomy. Patients with edema were significantly younger at the time of tracheostomy and more likely to be ventilator‐dependent due to bronchopulmonary dysplasia. Thirty patients (20%) developed SGS within 12–24 months of follow‐up. On univariable analysis, factors associated with increased odds of developing SGS included the presence of infraglottic edema at first DLB, gestational age, age at tracheostomy, and medical comorbidities; no significant association between SGS and other variables was identified in multivariable analysis; however, the adjusted odds ratio suggested a 94% increase in odds of developing SGS in patients with infraglottic edema [OR 1.94, p = 0.16]. Conclusions: Infraglottic edema is a common early finding after pediatric tracheostomy. While none of the variables of interest were associated with the development of SGS, the comparatively higher odds of SGS in patients with infraglottic edema suggest a potential link that warrants further investigation in prospective studies. Level of Evidence: 4.
- 14 November 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (6) , e70306
Open AccessInfraglottic Edema and Subglottic Stenosis in Tracheostomy‐Dependent Children: A Retrospective Cohort Study
Objective: Infraglottic edema secondary to swelling of the conus elasticus is a common observation in children after tracheostomy. We sought to describe the natural course of infra‐glottic edema as seen at first direct laryngoscopy and bronchoscopy (DLB) and explore its association with developing subglottic stenosis (SGS) in tracheostomy‐dependent children. Methods: A retrospective cohort study of children who underwent tracheostomy between 2012 and 2022 in a tertiary care children's hospital. Results: A total of 255 children (mean age 3.5 ± 5.3 years) were enrolled, of whom 150 met inclusion criteria. Infraglottic edema was observed in 74 patients (49.3%) at first DLB, performed a median of 1.7 months after tracheostomy. Patients with edema were significantly younger at the time of tracheostomy and more likely to be ventilator‐dependent due to bronchopulmonary dysplasia. Thirty patients (20%) developed SGS within 12–24 months of follow‐up. On univariable analysis, factors associated with increased odds of developing SGS included the presence of infraglottic edema at first DLB, gestational age, age at tracheostomy, and medical comorbidities; no significant association between SGS and other variables was identified in multivariable analysis; however, the adjusted odds ratio suggested a 94% increase in odds of developing SGS in patients with infraglottic edema [OR 1.94, p = 0.16]. Conclusions: Infraglottic edema is a common early finding after pediatric tracheostomy. While none of the variables of interest were associated with the development of SGS, the comparatively higher odds of SGS in patients with infraglottic edema suggest a potential link that warrants further investigation in prospective studies. Level of Evidence: 4.
- Open Access
- 5 November 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (6)
Tracheal Structural Changes in Tracheostomy‐Dependent Children With Bronchopulmonary Dysplasia
Background: Patients with severe Bronchopulmonary dysplasia (BPD) are prone to upper airway complications due to their need for prolonged intubation, early tracheostomy placement, and chronic high‐pressure ventilation. This study examines structural changes over time in tracheostomy‐dependent BPD patients compared to those without BPD. Methods: A retrospective cohort study of children who underwent tracheostomy at an age less than 6 months at a tertiary‐care children's hospital between January 2012 and December 2022. Results: A total of 82 patients underwent tracheostomy at an age of less than 6 months, of which 42 (51.2%) had BPD. Patients with BPD were older at the time of tracheostomy (4.44 vs. 3.36 months, p = 0.012) and had a younger gestational age (26.5 vs. 37.0 weeks, p < 0.001). Additionally, patients with BPD had higher rates of mechanical ventilation (42/42 vs. 24/40, p = 0.0018) and a greater number of days intubated prior to tracheostomy (92 vs. 21, p < 0.001). The median follow‐up period for all patients was 28.8 months [IQR = 36.8]. BPD infants were more likely to develop subglottic stenosis (30/42 vs. 16/40, p = 0.0082), glottic edema (32/42 vs. 19/40, p = 0.0074), require laryngotracheal reconstruction (16/42 vs. 5/40, p = 0.0095) and get decannulated (21/42 vs. 8/40, p = 0.0045) compared to infants without BPD. Conclusions: Tracheostomy‐dependent infants with BPD had higher rates of glottic edema, subglottic stenosis, and laryngotracheal reconstruction but were more likely to be decannulated. These findings suggest that, despite increased airway pathology, tracheostomy is a safe and effective intervention in this population, with outcomes comparable to other pediatric cohorts. Level of Evidence: 4.
- 5 November 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (6)
Open AccessTracheal Structural Changes in Tracheostomy‐Dependent Children With Bronchopulmonary Dysplasia
Background: Patients with severe Bronchopulmonary dysplasia (BPD) are prone to upper airway complications due to their need for prolonged intubation, early tracheostomy placement, and chronic high‐pressure ventilation. This study examines structural changes over time in tracheostomy‐dependent BPD patients compared to those without BPD. Methods: A retrospective cohort study of children who underwent tracheostomy at an age less than 6 months at a tertiary‐care children's hospital between January 2012 and December 2022. Results: A total of 82 patients underwent tracheostomy at an age of less than 6 months, of which 42 (51.2%) had BPD. Patients with BPD were older at the time of tracheostomy (4.44 vs. 3.36 months, p = 0.012) and had a younger gestational age (26.5 vs. 37.0 weeks, p < 0.001). Additionally, patients with BPD had higher rates of mechanical ventilation (42/42 vs. 24/40, p = 0.0018) and a greater number of days intubated prior to tracheostomy (92 vs. 21, p < 0.001). The median follow‐up period for all patients was 28.8 months [IQR = 36.8]. BPD infants were more likely to develop subglottic stenosis (30/42 vs. 16/40, p = 0.0082), glottic edema (32/42 vs. 19/40, p = 0.0074), require laryngotracheal reconstruction (16/42 vs. 5/40, p = 0.0095) and get decannulated (21/42 vs. 8/40, p = 0.0045) compared to infants without BPD. Conclusions: Tracheostomy‐dependent infants with BPD had higher rates of glottic edema, subglottic stenosis, and laryngotracheal reconstruction but were more likely to be decannulated. These findings suggest that, despite increased airway pathology, tracheostomy is a safe and effective intervention in this population, with outcomes comparable to other pediatric cohorts. Level of Evidence: 4.
- Open Access
- 21 August 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (4) , e70245
Prevalence, Associations, and Outcomes of Suprastomal Collapse After Pediatric Tracheostomy
Background: Suprastomal collapse is an understudied sequela of pediatric tracheostomy that may hinder decannulation. This study aims to investigate the prevalence and associated risk factors of suprastomal collapse following pediatric tracheostomy.Methods: A retrospective cohort study of children who underwent tracheostomy at a tertiary‐care children's hospital between 1/2012 and 12/2022.Results: A total of 255 children underwent tracheostomy, with 146 (57.3%) developing suprastomal collapse 10.7 ± 12.6 months after the tracheostomy. Patients younger than 6 months at the time of tracheostomy were twice as likely to develop suprastomal collapse (OR = 2.07, p = 0.0059). Direct laryngoscopy and bronchoscopy findings associated with increased odds of collapse included tracheobronchomalacia (OR = 1.72, p = 0.029), subglottic stenosis (OR = 2.96, p = 0.000028), and glottic or subglottic edema (OR = 2.4, p = 0.0012). The presence of peristomal granulation tissue and the surgical removal of this tissue were not significantly associated with the development of suprastomal collapse. On log‐rank analysis, the median time to develop collapse was significantly longer in patients who underwent granulation tissue removal compared to those who did not (8.2 vs. 4.8 months, p = 0.003). Patients with suprastomal collapse were significantly more likely to require upper airway surgery (OR 2.1, 95% CI 1.16–3.83, p = 0.0125) or laryngotracheal reconstruction (OR 3.4, 95% CI 1.41–9.64, p = 0.006) than those without collapse.Conclusions: Suprastomal collapse occurred in 60% of our cohort and was associated with the need for airway reconstruction. Contributing factors included age at tracheostomy, tracheobronchomalacia, subglottic stenosis, and glottic and subglottic edema. Despite concerns about weakening tracheal cartilage, granulation tissue removal was not associated with the development of collapse.Level of Evidence: 4.
- 21 August 2025
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 10 (4) , e70245
Open AccessPrevalence, Associations, and Outcomes of Suprastomal Collapse After Pediatric Tracheostomy
Background: Suprastomal collapse is an understudied sequela of pediatric tracheostomy that may hinder decannulation. This study aims to investigate the prevalence and associated risk factors of suprastomal collapse following pediatric tracheostomy.Methods: A retrospective cohort study of children who underwent tracheostomy at a tertiary‐care children's hospital between 1/2012 and 12/2022.Results: A total of 255 children underwent tracheostomy, with 146 (57.3%) developing suprastomal collapse 10.7 ± 12.6 months after the tracheostomy. Patients younger than 6 months at the time of tracheostomy were twice as likely to develop suprastomal collapse (OR = 2.07, p = 0.0059). Direct laryngoscopy and bronchoscopy findings associated with increased odds of collapse included tracheobronchomalacia (OR = 1.72, p = 0.029), subglottic stenosis (OR = 2.96, p = 0.000028), and glottic or subglottic edema (OR = 2.4, p = 0.0012). The presence of peristomal granulation tissue and the surgical removal of this tissue were not significantly associated with the development of suprastomal collapse. On log‐rank analysis, the median time to develop collapse was significantly longer in patients who underwent granulation tissue removal compared to those who did not (8.2 vs. 4.8 months, p = 0.003). Patients with suprastomal collapse were significantly more likely to require upper airway surgery (OR 2.1, 95% CI 1.16–3.83, p = 0.0125) or laryngotracheal reconstruction (OR 3.4, 95% CI 1.41–9.64, p = 0.006) than those without collapse.Conclusions: Suprastomal collapse occurred in 60% of our cohort and was associated with the need for airway reconstruction. Contributing factors included age at tracheostomy, tracheobronchomalacia, subglottic stenosis, and glottic and subglottic edema. Despite concerns about weakening tracheal cartilage, granulation tissue removal was not associated with the development of collapse.Level of Evidence: 4.
- Open Access
- 26 September 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (5) , e70006
Outcomes of heliox use in children with respiratory compromise: A 10‐year single institution experience
Objective: Heliox, a mixture of helium and oxygen, has been shown to improve laminar airflow and decrease airway resistance in children. This study aims to describe the outcomes of heliox use in children with respiratory compromise and to identify variables associated with a need for airway surgical intervention.Methods: A retrospective cohort study of patients who received heliox between 2012 and 2022 at a tertiary care children's hospital.Results: A hundred and thirty‐eight heliox treatments were recorded in 119 children. Twelve patients were excluded. Most (n = 100, 84%) patients had significant comorbidities. On average, patients spent a cumulative mean of 94 ± 187 h on heliox therapy per hospital admission. Patients with croup or asthma without known airway pathology presented at an older age than patients with other indications for heliox therapy (4.0 ± 4.7 vs. 2.2 ± 3.6 years, p = 0.04) and were significantly less likely to have background diseases (n = 14, 52% vs. n = 74, 93%, p < 0.0001). Overall, 51 (47.7%) patients were recommended tracheostomy placement, airway reconstruction, or palliative care. Cumulative use of heliox for more than 47 h was associated with an increased risk of needing tracheostomy or airway reconstruction (odds ratio 6.2, 95% confidence intervals 2.56–14.13, p < 0.0001). In multivariable regression analysis, neuromuscular disease, intracranial neuropathology, and cumulative time of heliox were associated with a need for definitive airway intervention.Conclusions: Heliox may be used as a temporizing agent in children with upper airway obstruction. The effectiveness of heliox use for more than 47 h in children, especially in the presence of neuromuscular disease and intracranial neuropathology should be reconsidered.Level of evidence: 4.
- 26 September 2024
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 9 (5) , e70006
Open AccessOutcomes of heliox use in children with respiratory compromise: A 10‐year single institution experience
Objective: Heliox, a mixture of helium and oxygen, has been shown to improve laminar airflow and decrease airway resistance in children. This study aims to describe the outcomes of heliox use in children with respiratory compromise and to identify variables associated with a need for airway surgical intervention.Methods: A retrospective cohort study of patients who received heliox between 2012 and 2022 at a tertiary care children's hospital.Results: A hundred and thirty‐eight heliox treatments were recorded in 119 children. Twelve patients were excluded. Most (n = 100, 84%) patients had significant comorbidities. On average, patients spent a cumulative mean of 94 ± 187 h on heliox therapy per hospital admission. Patients with croup or asthma without known airway pathology presented at an older age than patients with other indications for heliox therapy (4.0 ± 4.7 vs. 2.2 ± 3.6 years, p = 0.04) and were significantly less likely to have background diseases (n = 14, 52% vs. n = 74, 93%, p < 0.0001). Overall, 51 (47.7%) patients were recommended tracheostomy placement, airway reconstruction, or palliative care. Cumulative use of heliox for more than 47 h was associated with an increased risk of needing tracheostomy or airway reconstruction (odds ratio 6.2, 95% confidence intervals 2.56–14.13, p < 0.0001). In multivariable regression analysis, neuromuscular disease, intracranial neuropathology, and cumulative time of heliox were associated with a need for definitive airway intervention.Conclusions: Heliox may be used as a temporizing agent in children with upper airway obstruction. The effectiveness of heliox use for more than 47 h in children, especially in the presence of neuromuscular disease and intracranial neuropathology should be reconsidered.Level of evidence: 4.
- Open Access
- 18 January 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (7) , 3402-3405
The Airway Pocket: Novel Advancement in Endoscopic Submucosal Placement of Posterior Cartilage Graft
Endoscopic technology has increased our options for treatment of airway stenosis in a minimally invasive manner. This novel technique advances endoscopic posterior graft placement by creation of an airway pocket, potentially reducing risk of graft migration and improving outcomes. Laryngoscope, 2024.
- 18 January 2024
- Published by Wiley in The Laryngoscope
- Vol. 134 (7) , 3402-3405
Open AccessThe Airway Pocket: Novel Advancement in Endoscopic Submucosal Placement of Posterior Cartilage Graft
Endoscopic technology has increased our options for treatment of airway stenosis in a minimally invasive manner. This novel technique advances endoscopic posterior graft placement by creation of an airway pocket, potentially reducing risk of graft migration and improving outcomes. Laryngoscope, 2024.
- Open Access
- 12 October 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (S6)
Fluoroscopic‐Assisted Tongue Suspension: Advancement and Innovation in the Management of Complex Pediatric Obstructive Sleep Apnea
Objectives: The primary aim of this study is to describe a novel surgical technique developed for tongue base suspension (TBS). The second aim of this study is to assess the efficacy of the developed procedure by quantifying preoperative and postoperative polysomnographic outcomes for pediatric patients undergoing fluoroscopic‐assisted tongue suspension (FATS) with the Encore System. Our hypothesis is that our FATS technique will provide at least a 50% reduction in the Apnea/Hypopnea Index (AHI), including in the medically complex pediatric population.Study Design: Retrospective case series.Methods: An electronic medical record review was conducted of patients who underwent FATS by a single surgeon at a tertiary care medical center between December 2019 and June 2022. Inclusion criteria included all patients p < 0.01, 95% CI ‐29.0 to −11.4 events/h). The mean percentage decrease in AHI was 74.7%. The mean change in oAHI and RDI were −23.3 (±21.9) events/h (p < 0.01 95% CI‐ 39.9 to −21.4 events/h) and −22.5 (±21.5) events/h (p < 0.01, 95% CI‐ 31.5 to −12.4 events/h), respectively. The mean percentage decrease in oAHI and RDI was 75.6% and 73.8%, respectively. Surgical success occurred in 16 of the 21 (76%) patients. Of the 23 patients referred explicitly for tracheostomy placement, 21 (91%) were able to avoid tracheostomy placement secondary to improvements in OSA.Conclusions: Patients undergoing fluoroscopic‐assisted TBS revealed statistically significant improvements in AHI, oAHI, and RDI, with an overall surgical success rate of 76%. Complication rates were minimal, despite the complex nature of the study population. FATS should be considered a viable surgical approach in pediatric patients with an identified base of tongue obstruction and OSA.Level of Evidence: 4 Laryngoscope, 134:S1–S9, 2024
- 12 October 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (S6)
Open AccessFluoroscopic‐Assisted Tongue Suspension: Advancement and Innovation in the Management of Complex Pediatric Obstructive Sleep Apnea
Objectives: The primary aim of this study is to describe a novel surgical technique developed for tongue base suspension (TBS). The second aim of this study is to assess the efficacy of the developed procedure by quantifying preoperative and postoperative polysomnographic outcomes for pediatric patients undergoing fluoroscopic‐assisted tongue suspension (FATS) with the Encore System. Our hypothesis is that our FATS technique will provide at least a 50% reduction in the Apnea/Hypopnea Index (AHI), including in the medically complex pediatric population.Study Design: Retrospective case series.Methods: An electronic medical record review was conducted of patients who underwent FATS by a single surgeon at a tertiary care medical center between December 2019 and June 2022. Inclusion criteria included all patients p < 0.01, 95% CI ‐29.0 to −11.4 events/h). The mean percentage decrease in AHI was 74.7%. The mean change in oAHI and RDI were −23.3 (±21.9) events/h (p < 0.01 95% CI‐ 39.9 to −21.4 events/h) and −22.5 (±21.5) events/h (p < 0.01, 95% CI‐ 31.5 to −12.4 events/h), respectively. The mean percentage decrease in oAHI and RDI was 75.6% and 73.8%, respectively. Surgical success occurred in 16 of the 21 (76%) patients. Of the 23 patients referred explicitly for tracheostomy placement, 21 (91%) were able to avoid tracheostomy placement secondary to improvements in OSA.Conclusions: Patients undergoing fluoroscopic‐assisted TBS revealed statistically significant improvements in AHI, oAHI, and RDI, with an overall surgical success rate of 76%. Complication rates were minimal, despite the complex nature of the study population. FATS should be considered a viable surgical approach in pediatric patients with an identified base of tongue obstruction and OSA.Level of Evidence: 4 Laryngoscope, 134:S1–S9, 2024
- 9 March 2023
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 168, 111500
Comprehensive management of anterior drooling: An International Pediatric Otolaryngology Group (IPOG) consensus statement
- 9 March 2023
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 168, 111500
Comprehensive management of anterior drooling: An International Pediatric Otolaryngology Group (IPOG) consensus statement